President Trump has decided to nominate White House aide Heidi Overton to lead the Food and Drug Administration, according to a senior administration official. Why it matters: The agency was left in turmoil after the exit of former commissioner Marty Makary earlier this year, threatening the stability of U.S. drug development. Between the lines: Overton, currently deputy director of the White House Domestic Policy Council, was one of several candidates that the White House had been considering for weeks. - Bloomberg first reported that she was the president's choice. The intrigue: Overton appeared at last week's Oval Office signing of an executive order calling for an overhaul of the childhood vaccine schedule, including slimming down…
White House aide Heidi Overton, oncologist Jeffrey Vacirca and senior Pentagon health official Stephen Ferrara are all in the running to be the next FDA commissioner , sources tell Axios. Why it matters: The agency is moving to repair its relationship with industry and rehire critical staff since the departure of former commissioner Marty Makary. But a full-time political leader will ultimately decide the agency's direction. Driving the news: The three finalists are now being vetted. Overton and Vacirca were first reported as possible nominees by Bloomberg. Ferrara, now the Pentagon's principal deputy assistant secretary for health affairs, has not been previously reported. - Overton is currently deputy director of the White House…
The move comes one day after former Food and Drug Administration Commissioner Marty Makary resigned his post after a year on the job for the same reason, following approval of blueberry and mango flavored vape pods.
FDA Commissioner Marty Makary has resigned after reports that President Trump had pressured him to give approval to flavored vapes. #FDA #Trump #MartyMakary About Rising: Rising is a weekday morning show with bipartisan hosts that breaks the mold of morning TV by taking viewers inside the halls of Washington power like never before. The show leans into the day's political cycle with cutting edge analysis from DC insiders who can predict what is going to happen. It also sets the day's political agenda by breaking exclusive news with a team of scoop-driven reporters and demanding answers during interviews with the country's most important political newsmakers. Follow Rising on social media: Website: Hill.TV Facebook: facebook.com/HillTVLive/…
State of the Union: The outgoing agency head had angered pharma companies, pro-life Republicans, and vaping lobbyists. The post FDA Commissioner Makary Resigns Amid Controversy appeared first on The American Conservative .
The head of the Food and Drug Administration (FDA), Marty Makary, resigned Tuesday after leading the agency for just 13 months. Makary’s tenure at the FDA was marked by significant controversy, as he angered a number of political constituencies. Makary was elevated to head the FDA by President Donald Trump as part of the administration’s embrace of the Make America Healthy Again movement, represented by Health Secretary Robert F. Kennedy Jr. His time at the FDA saw a significant exodus of agency officials and employees, which created turmoil in the agency’s drug review program and frustrated pharmaceutical companies waiting for regulatory approval for their products. He also angered pro-life Republicans, who accused him of…Open
Trump-appointed FDA commissioner Marty Makary resigned. It's believed his resignation comes in part due to approval of fruit-flavored E-cigarettes. Opponents have questioned whether the change will influence teenagers to participate while proponents suggest it could help wean cigarette users off tobacco. #health #ecigarrettes #FDA
Marty Makary's departure from the Food and Drug Administration may remove one of the Trump administration's lightning rods for controversy. - But it won't solve the organizational upheaval and political jockeying that marked much of his 13-month tenure. Why it matters: There's lots of uncertainty around how the Senate will find the bandwidth to confirm another FDA commissioner while it considers President Trump's nominees for Centers for Disease Control and Prevention director and surgeon general . - The FDA itself is also facing other key internal vacancies, including for directors of the centers overseeing drugs and biologics. - And there are questions about whether a successor will continue efforts to streamline clinical trials and…
